Back to search
FDAFDA · Food and drugs·Recall number D-0841-2016

Ondansetron Tablets USP, 4 mg, 30 count bottles, Rx only, Manufactured by: Dr. Reddy's Laboratories, Bachupally, India --- NDC 56111-153-30

Published May 18, 2016 · Recall initiated: March 30, 2016

Summary

FDA records drug Class II recall D-0841-2016, published May 18, 2016 and initiated March 30, 2016. Recalling firm: Dr. Reddy's Laboratories, Inc.; Status: Terminated; Reported quantity: 50,280 bottles; Lot: Lot number C500691, exp 12/2016. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications; 12 month stability time point

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Dr. Reddy's Laboratories, Inc.
Distributor
Nationwide
Lot
Lot number C500691, exp 12/2016
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Ondansetron Tablets USP, 4 mg, 30 count bottles, Rx only, Manufactured by: Dr. Reddy's Laboratories, Bachupally, India --- NDC 56111-153-30 recalled?

Yes. FDA published recall D-0841-2016 on May 18, 2016. Reported hazard: Failed Impurities/Degradation Specifications; 12 month stability time point

What should I do if I have this product?

Voluntary: Firm initiated · Letter